Abbreviation New Drug Application (ANDA) suitablility for 7.5 mg of Cyclobenzaprine HCI-CLOSED
🏛 Food and Drug Administration (FDA)FDA-2003-P-0344
Documents
3
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Oct 1, 2003No comment period
- Other· Oct 1, 2003No comment period